Imuvac vaccine suspension for injection 0.5ml pre-filled syringes United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imuvac vaccine suspension for injection 0.5ml pre-filled syringes

viatris uk healthcare ltd - influenza virus surface antigens - suspension for injection

Influvac New Zealand - English - Medsafe (Medicines Safety Authority)

influvac

viatris limited - influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180); influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 15ug (a/singapore/infimh-16-0019/2016, nib-104); influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) - suspension for injection - 0.5 ml - active: influenza virus a/michigan/45/2015 (h1n1) pdm09 - like strain 15ug (a/singapore/gp1908/2015, ivr-180) influenza virus a/singapore/infimh-16-0019/2016 (h3n2) - like strain 15ug (a/singapore/infimh-16-0019/2016, nib-104) influenza virus b/phuket/3073/2013 - like strain 15ug (b/phuket/3073/2013, wild type) excipient: calcium chloride dihydrate dibasic sodium phosphate dihydrate magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride water for injection - for the prevention of influenza virus, types a and b in adults and children older than 6 months in accordance with the recommendations in the national immunisation guideline.

Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) European Union - English - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.

PANVAX H1N1 VACCINE JUNIOR H1N1 pandemic influenza vaccine (split-virion, inactivated) 0.25mL suspension for injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine junior h1n1 pandemic influenza vaccine (split-virion, inactivated) 0.25ml suspension for injection pre-filled syringe

seqirus pty ltd - influenza virus haemagglutinin, quantity: 7.5 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 5mL multi-dose injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 5ml multi-dose injection vial

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate; thiomersal - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 0.5mL injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 0.5ml injection pre-filled syringe

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

PANVAX H1N1 VACCINE, H1N1 pandemic influenza vaccine (split-virion, inactivated) 10mL multi-dose injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

panvax h1n1 vaccine, h1n1 pandemic influenza vaccine (split-virion, inactivated) 10ml multi-dose injection vial

seqirus pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate; monobasic sodium phosphate; potassium chloride; monobasic potassium phosphate; calcium chloride dihydrate; thiomersal - for active immunisation to prevent influenza disease caused by the influenza a (h1n1) virus, in persons from 6 months of age.

Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) European Union - English - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,

DURAMUNE ADULT C4 CANINE DISTEMPER, ADENOVIRUS, PARAINFLUENZA & PARVOVIRUS LIVE VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

duramune adult c4 canine distemper, adenovirus, parainfluenza & parvovirus live vaccine

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parainfluenza type 2; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parainfluenza type 2 vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | parvovirus

FLUZONE HIGH-DOSE inactivated trivalent influenza vaccine (Split Virion) 180mcg influenza virus haemagglutinin 0.5mL suspension Australia - English - Department of Health (Therapeutic Goods Administration)

fluzone high-dose inactivated trivalent influenza vaccine (split virion) 180mcg influenza virus haemagglutinin 0.5ml suspension

sanofi-aventis australia pty ltd - influenza virus haemagglutinin -